Elsevier

European Journal of Cancer

Volume 119, September 2019, Pages 200-201
European Journal of Cancer

Erratum
Erratum to ‘Second-line targeted therapies after nivolumab-ipilimumab failure in metastatic renal cell carcinoma’ [Eur J Cancer 108 (February 2019) 33–40]

https://doi.org/10.1016/j.ejca.2019.04.012

Cited by (0)

View Abstract